Global Digital PCR (DPCR) and QPCR Market Insights and Forecast to 2028

Digital PCR (DPCR) & QPCR Market Statistics 2028

The global Digital PCR (DPCR) and QPCR market size is estimated to be worth US$ 1419.2 million in 2022 and is forecast to a readjusted size of US$ 2165.8 million by 2028 with a CAGR of 7.3% during the review period.

Incidences of target diseases and genetic abnormalities are on the rise, necessitating the need for quick, precise, and accurate outcomes. Furthermore, the use of biomarker profiling for disease diagnosis is becoming more common. These factors are expected to drive the growth of the qPCR market.

Digital PCR (DPCR) & QPCR Market Trends

Growing applications of qPCR in Gene Expression, Pathogen Detection, Environmental Studies, siRNA, miRNA, lncRNA Detection, and Microarray Validation are likely to propel the qPCR market forward.

Furthermore, qPCR produces results that are quick, precise, and accurate. Real-time PCR is a type of PCR that collects data while the reaction is running, making it more accurate for DNA and RNA quantification and eliminating the need for time-consuming post-PCR procedures. The qPCR market is predicted to develop as a result of this aspect. qPCR assays are commonly employed in research laboratories to quantify gene copy number (gene dosage) in transformed cell lines or the presence of mutant genes. qPCR tests can be used in conjunction with reverse-transcription PCR (RT-PCR) to precisely quantify changes in gene expression.

The dPCR market is predicted to rise due to the growing usage of dPCR in cancer research and clinical microbiology. In addition, dPCR has been widely employed in a variety of applications, including mutation/SNP detection, genome editing detection, copy number variation, and standards validation.

Digital PCR also offers a wide range of uses in basic research, clinical diagnostics, and environmental testing. Its applications include pathogen detection and digestive health analysis, liquid biopsy for cancer monitoring, organ transplant rejection monitoring, and non-invasive prenatal testing for serious genetic abnormalities, copy number variation analysis, single gene expression analysis, rare sequence detection, gene expression profiling, and single-cell analysis, the detection of DNA contaminants in bioprocessing, etc. In addition, dPCR is commonly used as an orthogonal approach to confirm uncommon mutations discovered by next-generation sequencing (NGS) and to validate NGS libraries.

For detecting modest changes in the expression of a biomarker in response to therapeutic treatment, digital droplet PCR and quantitative polymerase chain reaction (qPCR) are useful methods. As a result, the growing usage of biomarker profiling for illness diagnosis is likely to drive the qPCR and dPCR market even further.

Covid-19 Impact on Digital PCR (DPCR) & QPCR Market

The COVID-19 pandemic had a significant impact on the healthcare industry. The diagnostics industry was the hardest hit, with a significant increase in the PCR market. As they are used for diagnostic and drug discovery, digital PCR and real-time PCR have seen a lot of interest. The development of a droplet digital PCR kit to detect COVID-19 has become a growing focus of industry participants. Regulatory agencies have expressed strong support for approving these tests in order to mitigate the effects of the COVID-19 pandemic.

Top Companies in Digital PCR (DPCR) & QPCR Market

Thermo Fisher, Roche, QIAGEN, Bio-rad, Agilent, and others are among the leading participants in the global Digital PCR (DPCR) and QPCR markets. The top five producers in the world control around 75% of the qPCR and dPCR market.

Digital PCR (DPCR) & QPCR Market Share Analysis

In terms of product, qPCR is the most popular, accounting for over 70% of the market. In terms of application, Research Use is the most common, followed by Clinical Use.

North America is the largest market, accounting for approximately half of all sales, followed by Europe and China, which each account for over 40%. The dominance of North America is attributed to the presence of major PCR manufacturers in this region, together with the rising demand for quick diagnostic tests, which is likely to fuel regional expansion.

Segment by Type

• dPCR
• qPCR

Segment by Application

• Clinical
• Research Institution
• Other

BY REGION

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic
• Rest of Europe
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia
• Latin America
• Mexico
• Brazil
• Rest of Latin America
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of MEA

BY COMPANY

• Thermo Fisher
• Roche
• QIAGEN
• Bio-rad
• Agilent
• Bioer
• Biosynex
• Esco
• Analytik Jena
• Techne
• Fluidigm
• RainDance Technologies